- Augments Senior Management Team with more than 30 Years Experience in
Biopharmaceutical Manufacturing, Engineering, Technical Services and
PRINCETON, N.J., Feb. 14 /PRNewswire/ -- Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced the appointment of Gary Swan as Vice President of Operations. In this newly created position, Mr. Swan will be responsible for leading Laureate's manufacturing operations, which include upstream processing, downstream processing, formulation and filling, facilities maintenance, warehouse operations, and environmental, health and safety regulations.
"We are delighted to welcome Gary to Laureate's senior leadership team," said Robert J. Broeze, Ph.D., President and CEO of Laureate. "With his strong background and extensive experience of more than 30 years in biopharmaceutical manufacturing operations, Gary will play a key leadership role in driving and managing Laureate's tremendous growth."
Gary's experience includes biopharmaceutical manufacturing,
engineering, technical services, validation, and quality control. Most
recently, Gary held the position of Senior Director of Manufacturing at
Nastech Pharmaceuticals in Hauppauge, NY, a publicly traded
biopharmaceutical company developing innovative products based on
proprietary molecular biology-based drug delivery technologies. At Nastech,
Gary directed the operations at two manufacturing sites in New York and
Washington. In this capacity, he also led the planning and scheduling of
the production of R&D, clinical, and licensed products. Prior to Nastech,
Gary was the Vice President of Operations at VI Technologies in Melville,
NY, a publicly traded biopharmaceutical company with a focus on deve
|SOURCE Laureate Pharma, Inc.|
Copyright©2008 PR Newswire.
All rights reserved